| 1 |
de Groot K, Harper L, Jayne DR, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial [J].Ann Intern Med, 2009, 150(10): 670-680.
|
| 2 |
Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis [J]. N Engl J Med, 2010, 363(3): 221-232.
|
| 3 |
Jones RB, Tervaert JW, Hauser T, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis [J]. N Engl J Med, 2010, 363(3): 211-220.
|
| 4 |
Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis [J]. J Am Soc Nephrol, 2007, 8(7): 2180-2188.
|
| 5 |
Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies [J]. N Engl J Med, 2003, 349(1): 36-44.
|
| 6 |
Hiemstra TF, Walsh M, Mahr A, et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial [J]. JAMA, 2010, 304(21): 2381-2388.
|
| 7 |
Pagnoux C, Mahr A, Hamidou MA, et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis [J]. N Engl J Med, 2008, 359(26): 2790-2803.
|
| 8 |
Stegeman CA, Tervaert JW, de Jong PE et al. Trimethoprimsulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group [J]. N Engl J Med, 1996, 335(1): 16-20.
|
| 9 |
Lionaki S, Hogan SL, Jennette CE et al. The clinical course of ANCA small-vessel vasculitis on chronic dialysis [J]. Kidney Int,2009, 76(6): 644-651.
|
| 10 |
Hogan SL, Falk RJ, Chin H, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibodyassociated small-vessel vasculitis [J]. Ann Intern Med, 2005,143(9): 621-631
|
| 11 |
Faurschou M, Sorensen IJ, Mellemkjaer L, et al. Malignancies in Wegener’s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients [J]. J Rheumatol, 2008, 35(1): 100-105.
|
| 12 |
Finkielman JD, Merkel PA, Schroeder D et al. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis [J]. Ann Intern Med, 2007, 147(9): 611-619.
|
| 13 |
Little MA, Hassan B, Jacques S, et al. Renal transplantation in systemic vasculitis: when is it safe [J]? Nephrol Dial Transplant,2009, 24(10): 3219-3225.
|